Life Sciences
The Microbial Bioburden of USP 797 Compliance
By Kimberly Kirkland, B.Sc., M.P.H, Deborah L. Jaeger, M.S
Simplifying environmental quality and control practices for pharmaceutical compounding
Containment of Hazardous Drugs: The New Paradigm
By Hank Rahe
Compared to pharmaceutical manufacturing, hazardous drugs have a narrow definition in the world of pharmacy. This article will compare and contrast the differences in the approach and knowledge base that exists in both worlds, in terms of defining and coping with the hazards these drugs represent.
Cleaning Protocols for USP 797 Compliance
By Karen Bonnell
Using the right techniques and procedures can make cleaning sterile compounding areas a matter of routine.
USP 797 Cleanroom Design
By Heather Wylie
Pharmacists can be in control of their cleanroom environment by understanding the critical elements.
Point of View: The Problem Is, We Can’t See the Problem: Or……Our Eyes Deceive Us
By Howard Siegerman, Ph.D.
Given that many companies need pristine surfaces for the manufacture of defect-free products, one might well ask why, forty years later, we should still be facing contamination issues and related product failures due to lack of proper wiping and surface cleaning?
Compounding of Sterile Medications In The Pharmacy - USP Chapter <797> Provides Guidance
By Scott Sutton, Ph.D.,, David Porter, Ph.D.
The USP has recently published a revised version of general chapter <797> Pharmacy Compounding — Sterile Preparations addressing sterile compounding. This chapter provides guidance on requirements for the compounding of safe, sterile pharmaceutical dosage forms in the pharmacy.